艾滋病病毒预防的暴露前预防：为何、是什么、何人适用及如何实施。
Pre-exposure Prophylaxis for HIV Prevention: Why, What, Who and How.
作者信息
Davies Olubanke, Ustianowski Andrew, Fox Julie
机构信息
Department of Genitourinary Medicine, Guys and St Thomas' NHS Trust, London, UK.
Infectious Diseases, North Manchester General Hospital, Manchester, UK.
出版信息
Infect Dis Ther. 2016 Dec;5(4):407-416. doi: 10.1007/s40121-016-0128-8. Epub 2016 Sep 27.
Abstract
Pre-exposure prophylaxis (PrEP) offers a promising new approach to HIV prevention. It is protective against HIV infection across populations and has few significant safety risks and little evidence of behavioural risk compensation. This article summarises the evidence behind HIV PrEP as an intervention, populations that may benefit, current guidelines and programmes, and the cost-effectiveness modelling of this strategy.
摘要
暴露前预防（PrEP）为艾滋病病毒（HIV）预防提供了一种有前景的新方法。它对所有人群预防HIV感染均有作用，且几乎没有重大安全风险，也几乎没有行为风险补偿的证据。本文总结了HIV暴露前预防作为一种干预措施的依据、可能受益的人群、现行指南和项目，以及该策略的成本效益模型。
相似文献
1
Pre-exposure Prophylaxis for HIV Prevention: Why, What, Who and How.艾滋病病毒预防的暴露前预防：为何、是什么、何人适用及如何实施。
Infect Dis Ther. 2016 Dec;5(4):407-416. doi: 10.1007/s40121-016-0128-8. Epub 2016 Sep 27.
2
Effectiveness and safety of oral HIV preexposure prophylaxis for all populations.针对所有人群的口服HIV暴露前预防的有效性和安全性。
AIDS. 2016 Jul 31;30(12):1973-83. doi: 10.1097/QAD.0000000000001145.
3
The impact, cost and cost-effectiveness of oral pre-exposure prophylaxis in sub-Saharan Africa: a scoping review of modelling contributions and way forward.撒哈拉以南非洲地区口服暴露前预防的影响、成本和成本效益：建模贡献及未来方向的范围综述。
J Int AIDS Soc. 2019 Sep;22(9):e25390. doi: 10.1002/jia2.25390.
4
Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature.多人群中使用口服暴露前预防（PrEP）预防HIV的价值观和偏好：文献系统综述
AIDS Behav. 2017 May;21(5):1325-1335. doi: 10.1007/s10461-016-1627-z.
5
The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study.秘鲁利马男男性行为者和跨性别女性中 HIV 预防的暴露前预防的潜在影响：一项数学建模研究。
PLoS Med. 2012;9(10):e1001323. doi: 10.1371/journal.pmed.1001323. Epub 2012 Oct 9.
6
Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.模拟口服暴露前预防在 13 个资源匮乏国家的影响和成本效益。
J Int AIDS Soc. 2020 Feb;23(2):e25451. doi: 10.1002/jia2.25451.
7
Towards a fair consideration of PrEP as part of combination HIV prevention in Latin America.在拉丁美洲将暴露前预防作为艾滋病毒联合预防的一部分进行公平考量。
J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21113. doi: 10.7448/IAS.19.7.21113. eCollection 2016.
8
Give PrEP a chance: moving on from the "risk compensation" concept.给予暴露前预防（PrEP）一个机会：走出“风险补偿”概念。
J Int AIDS Soc. 2019 Aug;22 Suppl 6(Suppl Suppl 6):e25351. doi: 10.1002/jia2.25351.
9
The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies.扩大艾滋病毒预防用暴露前预防措施的成本和影响：成本效益建模研究的系统评价。
PLoS Med. 2013;10(3):e1001401. doi: 10.1371/journal.pmed.1001401. Epub 2013 Mar 12.
10
Pre-exposure prophylaxis (PrEP) in an era of stalled HIV prevention: Can it change the game?暴露前预防（PrEP）在 HIV 预防停滞不前的时代：它能改变游戏规则吗？
Retrovirology. 2018 Apr 2;15(1):29. doi: 10.1186/s12977-018-0408-3.
引用本文的文献
1
Retention of clients in HIV oral pre-exposure prophylaxis care in Engela, Namibia.纳米比亚恩盖拉地区接受艾滋病毒口服暴露前预防护理的客户留存情况
Afr J Prim Health Care Fam Med. 2025 Jun 4;17(1):e1-e8. doi: 10.4102/phcfm.v17i1.4806.
2
Knowledge of PrEP Among Healthcare Workers in Substance Use Disorder Services: A Cross-Sectional Study in Italy.物质使用障碍服务领域医护人员对暴露前预防的认知：意大利的一项横断面研究。
J Community Health. 2025 Feb 9. doi: 10.1007/s10900-025-01445-x.
3
County-Level Factors Associated with Reversal of Insurer-Approved HIV Pre-Exposure Prophylaxis Prescriptions in the United States, 2018.2018年美国与保险公司批准的HIV暴露前预防处方逆转相关的县级因素
AIDS Behav. 2025 Apr;29(4):1089-1095. doi: 10.1007/s10461-024-04585-8. Epub 2024 Dec 30.
4
Exploring and Predicting HIV Preexposure Prophylaxis Adherence Patterns Among Men Who Have Sex With Men: Randomized Controlled Longitudinal Study of an mHealth Intervention in Western China.探索和预测男男性行为者中艾滋病病毒暴露前预防的依从模式：中国西部一项移动健康干预措施的随机对照纵向研究
JMIR Mhealth Uhealth. 2024 Dec 12;12:e58920. doi: 10.2196/58920.
5
Interventions to Improve Adherence to Oral Pre-exposure Prophylaxis: A Systematic Review and Network Meta-analysis.干预措施以提高口服暴露前预防用药的依从性：系统评价和网络荟萃分析。
AIDS Behav. 2024 Aug;28(8):2534-2546. doi: 10.1007/s10461-024-04365-4. Epub 2024 May 30.
6
Facilitators and barriers to community pharmacy PrEP delivery: a scoping review.促进和阻碍社区药房提供 PrEP 的因素：范围综述。
J Int AIDS Soc. 2024 Mar;27(3):e26232. doi: 10.1002/jia2.26232.
7
Awareness and Uptake of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention Among Men who have Sex with Men in Nepal.尼泊尔男男性行为者中艾滋病预防的事前预防（PrEP）知晓率和接受率。
J Community Health. 2024 Jun;49(3):514-525. doi: 10.1007/s10900-023-01318-1. Epub 2023 Dec 21.
8
PrEP risk perception and adherence among men who have sex with men: a prospective cohort study based on growth mixture model.男男性行为者中预防用抗逆转录病毒药物（PrEP）风险感知和依从性：基于增长混合模型的前瞻性队列研究。
BMC Infect Dis. 2022 Dec 30;22(1):969. doi: 10.1186/s12879-022-07966-3.
9
Effect of a Reminder System on Pre-exposure Prophylaxis Adherence in Men Who Have Sex With Men: Prospective Cohort Study Based on WeChat Intervention.基于微信干预的提醒系统对男男性行为者预防用药依从性的影响：前瞻性队列研究。
J Med Internet Res. 2022 Aug 11;24(8):e37936. doi: 10.2196/37936.
10
MHepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID.MHepPrEP：一项多地点多环境随机对照试验的研究方案，针对的是注射吸毒者的整合 HIV 预防和 HCV 护理。
Trials. 2022 Apr 23;23(1):341. doi: 10.1186/s13063-022-06085-3.
本文引用的文献
1
Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis.简短报告：在HIV-1暴露前预防背景下单剂量口服马拉维若的药代动力学/药效学研究
J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):252-257. doi: 10.1097/QAI.0000000000001108.
2
Effectiveness and safety of oral HIV preexposure prophylaxis for all populations.针对所有人群的口服HIV暴露前预防的有效性和安全性。
AIDS. 2016 Jul 31;30(12):1973-83. doi: 10.1097/QAD.0000000000001145.
3
Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States.美国针对注射吸毒者的艾滋病病毒暴露前预防的成本效益
Ann Intern Med. 2016 Jul 5;165(1):10-19. doi: 10.7326/M15-2634. Epub 2016 Apr 26.
4
Implementation and Operational Research: A Cost-Effective, Clinically Actionable Strategy for Targeting HIV Preexposure Prophylaxis to High-Risk Men Who Have Sex With Men.实施与运营研究：一种具有成本效益且可在临床上付诸行动的策略，用于将艾滋病病毒暴露前预防措施针对高危男男性行为者。
J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):e61-7. doi: 10.1097/QAI.0000000000000987.
5
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.使用含达匹韦林的阴道环预防女性感染HIV-1。
N Engl J Med. 2016 Dec 1;375(22):2121-2132. doi: 10.1056/NEJMoa1506110. Epub 2016 Feb 22.
6
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.按需暴露前预防治疗在 HIV-1 感染高危男性中的应用。
N Engl J Med. 2015 Dec 3;373(23):2237-46. doi: 10.1056/NEJMoa1506273. Epub 2015 Dec 1.
7
Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.与市级和社区性健康服务相结合的HIV感染暴露前预防
JAMA Intern Med. 2016 Jan;176(1):75-84. doi: 10.1001/jamainternmed.2015.4683.
8
What do we know about the cost-effectiveness of HIV preexposure prophylaxis, and is it affordable?我们对艾滋病病毒暴露前预防的成本效益了解多少，它是否负担得起？
Curr Opin HIV AIDS. 2016 Jan;11(1):56-66. doi: 10.1097/COH.0000000000000217.
9
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.暴露前预防以预防HIV-1感染（PROUD）：一项实用开放标签随机试验试点阶段的有效性结果
Lancet. 2016 Jan 2;387(10013):53-60. doi: 10.1016/S0140-6736(15)00056-2. Epub 2015 Sep 9.
10
Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.模拟尼日利亚HIV血清学不一致夫妇联合预防的影响及成本效益。
AIDS. 2015 Sep 24;29(15):2035-44. doi: 10.1097/QAD.0000000000000798.
Zotero 插件